Franc Gay summariz fdgs om the FORTE trial to pare rfilzomib bo wh eher len/x or cyclophosphami/x, NDMM patients
Contents:
- FRANC GAY | ASCO 2018 | UPDATE ON THE FORTE TRIAL ACRDG TO RISK STAT NDMM
- FRANC GAY
- FRANC GAY
- FRANC GAY
FRANC GAY | ASCO 2018 | UPDATE ON THE FORTE TRIAL ACRDG TO RISK STAT NDMM
* francesca gay multiple myeloma *
Franc Gay is Associate Profsor the Universy of Toro, Department of Molecular Btechnology and Health Scienc, and works as hematologist at the SSD Clil trials on-ematology and multiple myeloma, Divisn of Hematology, Azienda Ospedaliero-Universaria Ctà lla Salute e lla Scienza di Toro, Italy.
Gay’s ma rearch foc on the diagnosis and the clil and experimental treatment of patients wh multiple myeloma and associated disorrs, particularly of newly diagnosed patients eligible for tologo stem-cell transplantatn. Franc Gay, MD,. Franc Gay, Chiara Cerrato, Delia Rota Slabri, Moni Galli, Angelo Belotti, Elena Zamagni, Anton Ledda, Mariella Grasso, Emanuele Angelucci, Anna Mara Liberati, Patrizia Tosi, Franc Pisani, Stefano Spada, Ombretta Annibali, Anna Baraldi, Paola Omedé, Piero Galieni, Ra Rizzi, Norbert Psta, Sonia Ronni, Donatella Vcelli, Anna Maria Cao, Massimo Offidani, Anton Palumbo, Pellegro Mto, Michele Cavo, Mar Bocdoro; Carfilzomib-Lenalidomi-Dexamethasone (KRd) Inductn-Autologo Transplant (ASCT)-Krd Consolidatn Vs KRd 12 Cycl Vs Carfilzomib-Cyclophosphami-Dexamethasone (KCd) Inductn-ASCT-KCd Consolidatn: Analysis of the Randomized Forte Trial Newly Diagnosed Multiple Myeloma (NDMM).
FRANC GAY
Franc Gay speaks exclively to VJHemOnc on Treatg myeloma and associated disorrs. Watch terviews and discsns wh Franc Gay here. * francesca gay multiple myeloma *
Ma R, Mto P, Rota-Slabri D, Paris L, Gamberi B, Palmas A, Aquo S, Fabriis P, Giuliani N, De Rosa L, Gozzetti A, Celli C, Bertami L, Capra A, Oddolo D, Vcelli ID, Ronni S, Pavone V, Psta N, Cea M, Froni F, Ballanti S, Grasso M, Zamagni E, Belotti A, Bocdoro M, Gay F.
FRANC GAY
Cavo M, Gay F, Beksac M, Pantani L, Petcci MT, Dimopoulos MA, Dozza L, van r Holt B, Zweegman S, Oliva S, van r Veln VHJ, Zamagni E, Palumbo GA, Patriar F, Montef V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockew A, Ballanti S, Offidani M, Vcelli ID, Zambello R, Liberati AM, Anrsen NF, Broijl A, Troia R, Pasrella A, Benevolo G, Lev MD, Bos G, Ludwig H, Aquo S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von m Borne PA, Carava di Torto T, Zanr T, Drisen C, Specchia G, Waage A, Gimsg P, Mellqvist UH, van Marwijk Kooy M, Mnema M, Mandigers C, Cao AM, Palmas A, Carvalho S, Spencer A, Bocdoro M, Sonneveld P.
Gay F, Oliva S, Petcci MT, Conticello C, Catalano L, Corradi P, Sislchi A, Magarotto V, Pour L, Carella A, Malfano A, Petrò D, Evangelista A, Spada S, Psta N, Omedè P, Campbell P, Liberati AM, Offidani M, Ria R, Puli S, Patriar F, Hajek R, Spencer A, Bocdoro M, Palumbo A. Gay F, et al.
FRANC GAY
Franc Gay is Associate Profsor the Univeristy of Toro, and works as hematologist at the Myeloma Un, Divisn of Hematology, Azienda Ospedaliero-Universaria Ctà lla Salute e lla Scienza di Toro, Italy. Joseph, 2 Franc Gay, 1 Efstaths Kastris, 3 Maria Tera Petcci, 4 Jonathan L.